Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults

Sponsor
Complejo Hospitalario Universitario de Albacete
Study ID
NCT04362943
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
70 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Baricitinib or Anakinra — DRUG
    Treatment with either Baricitinib or Anakinra during hospitalization, in real world, and under usual clinical care.

Study Details

Retrospective clinical-epidemiological study aimed at characterizing COVID-19 disease in adults older than 70 years, hospitalized in the "Perpetuo Socorro" Hospital of Albacete (Spain) from 09/03/2020 until 20/04/2020. Secondary objectives will be to analyze clinical-epidemiological characteristics of COVID-19 patients treated with Baricitinib or Anakinra, and to describe the efficacy and secondary effects of those drugs.

Key Dates

Start date
Apr 20, 2020
Status verified
Jul 2021
Primary completion
Apr 15, 2021
Completion
Apr 15, 2021

Study Design

Enrollment
576 participants (actual)

Arms

  • Arm: Complete sample
    Adults older than 70 years hospitalized for COVID-19 disease between 09/03/2020 and 20/04/2020 in the "Perpetuo Socorro" Hospital of Albacete (Spain)
  • Arm: Baricitinib
    Adults older than 70 years hospitalized for COVID-19 disease between 09/03/2020 and 20/04/2020 and receiving Baricitinib.
  • Arm: Anakinra
    Adults older than 70 years hospitalized for COVID-19 disease between 09/03/2020 and 20/04/2020 and receiving Anakinra.

Primary Outcome Measure

Mortality [ Time Frame: 1 month ]

Related Studies